MedTrace Logo

Oral Dexmedetomidine vs Midazoam For Premedication

NCT03357718 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2020-05-29

No results posted yet for this study

Summary

The aim of this study was to compare the effect of 2 µg/kg of oral dexmedetomidine (DEX) and 0.5 mg/kg dormicum as premedication among children undergoing dental procedures.

Conditions

  • Premedication

Interventions

DRUG

Precedex

2 µg/kg oral

DRUG

Midazolam

0.5 mg/kg

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Principal Investigators

  • Sultan KELES, Dr. · Adnan Menderes University Faculty of Dentistry Aydın

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2017-05-30
Completion
2017-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03357718 on ClinicalTrials.gov